Impact of HIV infection in patients infected with chronic HCV (genotypes 1a and 3a): virological and clinical changes

References

• Spengler U. Management of end-stage liver disease in HIV/hepatitis C virus co-infection. Curr Opin HIV AIDS. 2011;6(6):527–533.10.1097/COH.0b013e32834bc691
   PubMed Web of Science ®Google Scholar
• Puoti M, Rossotti R, Travi G, Panzeri C, Morreale M, Chiari E, et al. Optimizing treatment in HIV/HCV coinfection. Dig Liver Dis. 2013;45(5):S355–S362.10.1016/j.dld.2013.09.001
   Google Scholar
• Barcaui HS, Tavares GC, May SB, Brandão-Mello CE, Amendola Pires MM, Barroso PF. Low rates of sustained virologic response with peginterferon plus ribavirin for chronic hepatitis C virus infection in HIV infected patients in Rio de Janeiro, Brazil. PLoS ONE. 2013;8(7):e67734.10.1371/journal.pone.0067734
   Google Scholar
• Ashrafi Hafez A, Baharlou R, Mousavi Nasab SD, Ahmadi Vasmehjani A, Shayestehpour M, Joharinia N, et al. Molecular epidemiology of different hepatitis C genotypes in serum and peripheral blood mononuclear cells in Jahrom city of Iran. Hepat mon. 2014;14(5):e16391.
   Google Scholar
• Tedaldi EM, Hullsiek KH, Malvestutto CD, Arduino RC, Fisher EJ, Gaglio PJ, et al. Prevalence and characteristics of hepatitis C virus coinfection in a human immunodeficiency virus clinical trials group: the terry beirn community programs for clinical research on AIDS. Clin Infect Dis. 2003;36(10):1313–1317.10.1086/cid.2003.36.issue-10
   PubMed Web of Science ®Google Scholar
• Urbanus AT, van de Laar TJ, Stolte IG, Schinkel J, Heijman T, Coutinho RA, et al. Hepatitis C virus infections among HIV-infected men who have sex with men: an expanding epidemic. AIDS. 2009;23(12):F1–F7.10.1097/QAD.0b013e32832e5631
   PubMed Web of Science ®Google Scholar
• Pappalardo BL. Influence of maternal human immunodeficiency virus (HIV) co-infection on vertical transmission of hepatitis C virus (HCV): a meta-analysis. Int J Epidemiol. 2003;32(5):727–734.10.1093/ije/dyg107
   PubMed Web of Science ®Google Scholar
• Miller CL, Wood E, Spittal PM, Li K, Frankish JC, Braitstein P, et al. The future face of coinfection: prevalence and incidence of HIV and hepatitis C virus coinfection among young injection drug users. J Acquir Immune Defic Syndr. 2004;36(2):743–749.10.1097/00126334-200406010-00012
   PubMed Web of Science ®Google Scholar
• Tan Y, Wei QH, Chen LJ, Chan PC, Lai WS, He ML, et al. Molecular epidemiology of HCV monoinfection and HIV/HCV coinfection in injection drug users in Liuzhou, Southern China. PLoS ONE. 2008;3(10):e3608.10.1371/journal.pone.0003608
   Google Scholar
• Ramos B, Núñez M, Toro C, Sheldon J, García-Samaniego J, Ríos P, et al. Changes in the distribution of hepatitis C virus (HCV) genotypes over time in Spain according to HIV serostatus: implications for HCV therapy in HCV/HIV-coinfected patients. J Infec. 2007;54(2):173–179.10.1016/j.jinf.2006.02.006
   PubMed Web of Science ®Google Scholar
• Hosseini M, Seyed Alinaghi S, Kheirandish P, Esmaeli Javid G, Shirzad H, Karami N, et al. Prevalence and correlates of co-infection with human immunodeficiency virus and hepatitis C virus in male injection drug users in Iran. Arch Iran Med. 2010;13(4):318–323.
   PubMed Web of Science ®Google Scholar
• Thein H-H, Yi Q, Dore GJ, Krahn MD. Natural history of hepatitis C virus infection in HIV-infected individuals and the impact of HIV in the era of highly active antiretroviral therapy: a meta-analysis. AIDS. 2008;22(15):1979–1991.10.1097/QAD.0b013e32830e6d51
   PubMed Web of Science ®Google Scholar
• Neukam K, García-Rey S, Cifuentes C, Macías J, Mira JA, Vázquez MJ, et al. HIV-coinfection leads to a modest increase in plasma HCV-RNA load in patients with chronic HCV infection. Antiviral Res. 2012;95(3):212–215.10.1016/j.antiviral.2012.06.009
   PubMed Web of Science ®Google Scholar
• Carrat F, Bani-Sadr F, Pol S, Rosenthal E, Lunel-Fabiani F, Benzekri A, et al. Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial. JAMA. 2004;292(23):2839–2848.10.1001/jama.292.23.2839
   PubMed Web of Science ®Google Scholar
• Mehta SH, Moore RD, Thomas DL, Chaisson RE, Sulkowski MS. The effect of HAART and HCV infection on the development of hyperglycemia among HIV-infected persons. J Acquir Immune Defic Syndr. 2003;33(5):577–584.10.1097/00126334-200308150-00005
   PubMed Web of Science ®Google Scholar
• Casalino E, Wolff M, Ravaud P, Choquet C, Bruneel F, Regnier B. Impact of HAART advent on admission patterns and survival in HIV-infected patients admitted to an intensive care unit. AIDS. 2004;18(10):1429–1433.10.1097/01.aids.0000131301.55204.a7
   PubMed Web of Science ®Google Scholar
• Palella FJ Jr, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med. 1998;338(13):853–860.10.1056/NEJM199803263381301
   PubMed Web of Science ®Google Scholar
• Taye S, Lakew M. Impact of hepatitis C virus co-infection on HIV patients before and after highly active antiretroviral therapy: an immunological and clinical chemistry observation, Addis Ababa, Ethiopia. BMC immunol. 2013;14(1):23.10.1186/1471-2172-14-23
   PubMed Web of Science ®Google Scholar
• Operskalski EA, Kovacs A. HIV/HCV Co-infection: pathogenesis, clinical complications, treatment, and new therapeutic technologies. Curr HIV/AIDS Rep. 2011;8(1):12–22.10.1007/s11904-010-0071-3
   PubMedGoogle Scholar
• Hernandez MD, Sherman KE. HIV/HCV coinfection natural history and disease progression, a review of the most recent literature. Curr Opin HIV AIDS. 2011;6(6):478–482.10.1097/COH.0b013e32834bd365
   PubMed Web of Science ®Google Scholar
• McGovern BH. Hepatitis C in the HIV-infected patient. J Acquir Immune Defic Syndr. 2007;45(2):S47–S56.10.1097/QAI.0b013e318068d190
   Google Scholar
• Kim AY, Lauer GM, Ouchi K, Addo MM, Lucas M, zur Wiesch JS, et al. The magnitude and breadth of hepatitis C virus–specific CD8+ T cells depend on absolute CD4+ T-cell count in individuals coinfected with HIV-1. Blood. 2005;105(3):1170–1178.
   Google Scholar
• Gadalla SM, Preiss LR, Eyster ME, Goedert JJ. Correlates of high hepatitis C virus RNA load in a cohort of HIV-negative and HIV-positive individuals with haemophilia. J Viral Hepat. 2011;18(3):161–169.10.1111/jvh.2011.18.issue-3
   PubMed Web of Science ®Google Scholar
• Mousavi Nasab SD, Baharlou R, Piroozmand A, Toghyani H, Shadmand E, Fazel H, et al. Distribution of IL-28B genotypes in patients with hepatitis C and healthy individuals in Jahrom city. Gastroenterol Hepatol Bed Bench. 2015;8(4):278–287.
   PubMedGoogle Scholar
• Ashrafi Hafez A, Ahmadi Vasmehjani A, Baharlou R, Mousavi Nasab SD, Davami MH, Najafi A, et al. Analytical assessment of interleukin-23 and -27 cytokines in healthy people and patients with hepatitis C virus infection (Genotypes 1 and 3a). Hepat Mon. 2014;14(9):e21000.
   Google Scholar
• Schnuriger A, Dominguez S, Guiguet M, Harfouch S, Samri A, Ouazene Z, et al. Acute hepatitis C in HIV-infected patients: rare spontaneous clearance correlates with weak memory CD4 T-cell responses to hepatitis C virus. AIDS. 2009;23(16):2079–2089.10.1097/QAD.0b013e328330ed24
   PubMed Web of Science ®Google Scholar
• Sulkowski M, Benhamou Y. Therapeutic issues in HIV/HCV-coinfected patients. J Viral Hepat. 2007;14(6):371–386.10.1111/jvh.2007.14.issue-6
   PubMed Web of Science ®Google Scholar
• Antonishyn NA, Ast VM, McDonald RR, Chaudhary RK, Lin L, Andonov AP, et al. Rapid genotyping of hepatitis C virus by primer-specific extension analysis. J clin microbiol. 2005;43(10):5158–5163.10.1128/JCM.43.10.5158-5163.2005
   PubMed Web of Science ®Google Scholar
• Operskalski EA, Mack WJ, Strickler HD, French AL, Augenbraun M, Tien PC, et al. Factors associated with hepatitis C viremia in a large cohort of HIV-infected and-uninfected women. J Clin virol. 2008;41(4):255–263.10.1016/j.jcv.2007.08.021
   PubMed Web of Science ®Google Scholar
• Trimoulet P, Neau D, Le Bail B, Rullier A, Winnock M, Galperine T, et al. Intrahepatic HCV RNA loads in 37 HIV-HCV co-infected patients with controlled HIV infection. J Med Virol. 2002;67(2):143–151.10.1002/jmv.v67:2
   PubMed Web of Science ®Google Scholar
• Daar ES, Lynn H, Donfield S, Gomperts E, Hilgartner MW, Hoots WK, et al. Relation between HIV-1 and hepatitis C viral load in patients with hemophilia. J Acquir Immune Defic Syndr. 2001;26(5):466–472.10.1097/00126334-200104150-00011
   PubMed Web of Science ®Google Scholar
• Shyam K, Shyla J, Amy L, Shuying L, Mary M, Julia AM, et al. Changes in hepatitis C viral response after initiation of highly active antiretroviral therapy and control of HIV viremia in chronically coinfected individuals. HIV Clin Trials. 2004;5(1):25–32.10.1310/CVEU-980Q-MPRA-XRG8
   PubMed Web of Science ®Google Scholar
• Torre D, Tambini R, Cadario F, Barbarini G, Moroni M, Basilico C. Evolution of coinfection with human immunodeficiency virus and hepatitis C virus in patients treated with highly active antiretroviral therapy. Clin Infect Dis. 2001;33(9):1579–1585.10.1086/cid.2001.33.issue-9
   PubMed Web of Science ®Google Scholar
• Bower WA, Culver DH, Castor D, Wu Y, James VN, Zheng H, et al. Changes in hepatitis C virus (HCV) viral load and interferon-α levels in HIV/HCV-coinfected patients treated with highly active antiretroviral therapy. J Acquir Immune Defic Syndr. 2006;42(3):293–297.10.1097/01.qai.0000221689.77220.42
   PubMed Web of Science ®Google Scholar
• Chung RT, Evans SR, Yang Y, Theodore D, Valdez H, Clark R, et al. Immune recovery is associated with persistent rise in hepatitis C virus RNA, infrequent liver test flares, and is not impaired by hepatitis C virus in coinfected subjects. AIDS. 2002;16(14):1915–1923.10.1097/00002030-200209270-00008
   PubMed Web of Science ®Google Scholar
• Kamal SM, Ismail A, Graham CS, He Q, Rasenack JW, Peters T, et al. Pegylated interferon α therapy in acute hepatitis C: relation to hepatitis C virus–specific T cell response kinetics. Hepatology. 2004;39(6):1721–1731.10.1002/(ISSN)1527-3350
   PubMed Web of Science ®Google Scholar
• Ragni MV, Bontempo FA. Increase in hepatitis C virus load in hemophiliacs during treatment with highly active antiretroviral therapy. J Infect Dis. 1999;180(6):2027–2029.10.1086/jid.1999.180.issue-6
   PubMed Web of Science ®Google Scholar
• Mauss S, Berg T, Rockstroh J, Sarrazin C, Wedemeyer H. A clinical textbook. 2nd ed. Düsseldorf: Flying Publisher; 2010.
   Google Scholar
• Rahimi-Movaghar A, Amin-Esmaeili M, Haghdoost AA, Sadeghirad B, Mohraz M. HIV prevalence amongst injecting drug users in Iran: a systematic review of studies conducted during the decade 1998-2007. Int J Drug Policy. 2012;23(4):271–278.10.1016/j.drugpo.2011.09.002
   PubMed Web of Science ®Google Scholar